1,670 result(s) found
Too Important to Fail? My Misguided Trust in a Doomed Crypto Bank's Resilience
https://www.fool.com/investing/2024/01/29/too-important-to-fail-my-misguided-trust-in-a-doom/?source=iedfolrf0000001
Jan 29, 2024 - What's the point of making big mistakes if you didn't learn anything from the painful errors? This Fool doesn't mind sharing those hard-won insights for free.
0
Big Earnings Week Ahead
https://www.zacks.com/stock/news/2217255/big-earnings-week-ahead?cid=CS-ZC-FT-economic_highlights-2217255
Jan 29, 2024 - Big Earnings Week Ahead
0
Mid-America Apartment Communities: Apartment Avalanche Will Result In Big Downgrades To Outlook
https://seekingalpha.com/article/4665678-mid-america-apartment-communities-apartment-avalanche-will-result-in-big-downgrades-to-outlook?source=feed_all_articles
Jan 28, 2024 - As Mid-America Apartment Communities has become cheaper, MAA.PI has been priced to even more ridiculous levels. Click here for a detailed analysis.
0
Cigna Q4 Preview: The Analysts' Whisper - Deciphering Cigna's Next Big Leap
https://seekingalpha.com/article/4665660-cigna-q4-preview-the-analysts-whisper-deciphering-cignas-next-big-leap?source=feed_all_articles
Jan 28, 2024 - Cigna's subsidiary Evernorth is driving innovation and growth in the healthcare sector. Click here to read why CI stock is a Strong Buy.
0
PEO: Deep Discount And Big Oil Exposure
https://seekingalpha.com/article/4665657-peo-deep-discount-big-oil-exposure?source=feed_tag_etf_portfolio_strategy
Jan 28, 2024 - PEO puts an emphasis on a fairly narrow portfolio, with Exxon Mobil and Chevron as top holdings in significant allocations. Read why PEO is a Hold.
0
A Little Good News for Rivian Investors
https://www.fool.com/investing/2024/01/28/a-little-good-news-for-rivian-investors/?source=iedfolrf0000001
Jan 28, 2024 - Leasing is a big deal for high-priced-vehicle demand, and Rivian might have just unlocked more with this move.
0
Big pharma is at a crossroads, as J&J, Merck and others prepare to lose heaps of revenue from blockbuster drugs
https://www.cnbc.com/2024/01/28/big-pharma-merck-bristol-myers-jj-prepare-to-lose-revenue.html
Jan 28, 2024 - Fast-approaching patent expirations will take a bite out of revenues and put the industry's top players in the hot seat over the next few years.
0
Big Pharma earnings season in spotlight amid positive sentiment
https://seekingalpha.com/news/4059361-big-pharma-earnings-spotlight-positive-sentiment?source=feed_sector_healthcare
Jan 28, 2024 - Barclays and UBS preview Q4 2023 earnings for bigpharma, with Eli Lilly (LLY), AbbVie (ABBV), Merck (MRK) and Amgen (AMGN) among their key picks. Read more here.
0
1 Big Reason to Like Procter & Gamble Stock in 2024
https://www.fool.com/investing/2024/01/28/1-big-reason-to-like-procter-gamble-stock-in-2024/?source=iedfolrf0000001
Jan 28, 2024 - The consumer staples giant had some good news for investors in its recent operating update.
0
Big Tech Earnings Loom: What Can Investors Expect?
https://www.zacks.com/commentary/2216675/big-tech-earnings-loom-what-can-investors-expect?cid=CS-ZC-FT-earnings_preview-2216675
Jan 26, 2024 - A big part of Tech's improved earnings outlook has been a function of more effective cost controls that have helped stabilize margins. What will the Q4 results show?
0